A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

Clinical trial NCT02797951 · COMPLETED

Trial details

NCT number: NCT02797951
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Episodic Cluster Headache Chronic Cluster Headache

Start date: 2016-07-13
Primary completion: 2021-01-21
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.